SGS is introducing new in vitro toxicology services at its Mississauga, Canada lab. The investment in instruments and expansion of the lab’s capabilities will allow SGS clients to establish toxicological profiles of bio/pharmaceuticals, medical devices, cosmetics and chemicals.    The investment includes an expansion of existing cell/tissue culture capabilities, flow cytometry and mass spectrometry facilities, along with the introduction of high throughput screening, automation, and multiplexi...